SHSE:601336 (China)
Â
Class A
Â¥
47.7
-0.52 (-1.08%)
Apr 11
What is a stock summary page? Click here for an overview.
Business Description
New China Life Insurance Co Ltd
NAICS : 524113
SIC : 6311
ISIN : CNE1000019Y0
Share Class Description:
SHSE:601336: Class ACompare
Compare
Traded in other countries / regions
601336.China01336.Hong KongNCL.GermanyNWWCF.USA Index Membership
SSE Composite IndexCSI 300 IndexiShares MSCI ACWI Ex US Index Fund IPO Date
2011-12-16Description
New China Life Insurance is headquartered in Beijing and was established in 1996 by a combination of state-owned enterprises and private firms. It is currently the fourth-largest life insurer in China based on total assets. The company is partly owned by Huijin Investment, the government's investment arm, which holds a 31% stake in New China Life. In 2011, the company was listed on both the Hong Kong and Shanghai stock exchanges.New China Life offers a wide range of life insurance products and services to both individual and institutional customers through its extensive distribution networks and diverse marketing channels. Additionally, it manages and invests insurance funds through its subsidiaries, including its Asset Management Company and Asset Management Company (Hong Kong).
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.24 | |||||
| Equity-to-Asset | 0.06 | |||||
| Debt-to-Equity | 0.32 | |||||
| Debt-to-EBITDA | N/A |
N/A
|
N/A
| |||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 7/9 | |||||
| Beneish M-Score | -2.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -32.6 | |||||
| 3-Year EPS without NRI Growth Rate | 20.9 | |||||
| 3-Year FCF Growth Rate | 10.5 | |||||
| 3-Year Book Growth Rate | -3.9 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | -6.76 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.63 | |||||
| 9-Day RSI | 35.39 | |||||
| 14-Day RSI | 40.65 | |||||
| 3-1 Month Momentum % | 6.64 | |||||
| 6-1 Month Momentum % | -3.4 | |||||
| 12-1 Month Momentum % | 65.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.91 | |||||
| Dividend Payout Ratio | 0.17 | |||||
| Forward Dividend Yield % | 2.91 | |||||
| 5-Year Yield-on-Cost % | 3.95 | |||||
| Shareholder Yield % | -9.11 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Net Margin % | 38.56 | |||||
| FCF Margin % | 139.96 | |||||
| ROE % | 27.53 | |||||
| ROA % | 1.71 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 5.67 | |||||
| Forward PE Ratio | 8.1 | |||||
| PE Ratio without NRI | 5.67 | |||||
| Shiller PE Ratio | 11.29 | |||||
| Price-to-Owner-Earnings | 6.19 | |||||
| PS Ratio | 2.19 | |||||
| PB Ratio | 1.55 | |||||
| Price-to-Tangible-Book | 1.61 | |||||
| Price-to-Free-Cash-Flow | 1.56 | |||||
| Price-to-Operating-Cash-Flow | 1.55 | |||||
| EV-to-Revenue | 1.75 | |||||
| EV-to-Forward-Revenue | 1.21 | |||||
| EV-to-FCF | 1.25 | |||||
| Price-to-GF-Value | 1.39 | |||||
| Price-to-Projected-FCF | 0.2 | |||||
| Price-to-Median-PS-Value | 2.27 | |||||
| Price-to-Graham-Number | 0.64 | |||||
| FCF Yield % | 75.51 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
New China Life Insurance Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 68,014 | ||
| EPS (TTM) (Â¥) | 8.41 | ||
| Beta | 1.84 | ||
| 3-Year Sharpe Ratio | 0.39 | ||
| 3-Year Sortino Ratio | 0.81 | ||
| Volatility % | 41.21 | ||
| 14-Day RSI | 40.65 | ||
| 14-Day ATR (Â¥) | 1.655445 | ||
| 20-Day SMA (Â¥) | 50.9595 | ||
| 12-1 Month Momentum % | 65.23 | ||
| 52-Week Range (Â¥) | 27.68 - 58.03 | ||
| Shares Outstanding (Mil) | 3,119.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
New China Life Insurance Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
New China Life Insurance Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
New China Life Insurance Co Ltd Frequently Asked Questions
What is New China Life Insurance Co Ltd(SHSE:601336)'s stock price today?
The current price of SHSE:601336 is ¥47.70. The 52 week high of SHSE:601336 is ¥58.03 and 52 week low is ¥27.68.
When is next earnings date of New China Life Insurance Co Ltd(SHSE:601336)?
The next earnings date of New China Life Insurance Co Ltd(SHSE:601336) is 2025-04-30 Est..
Does New China Life Insurance Co Ltd(SHSE:601336) pay dividends? If so, how much?
The Dividend Yield %  of New China Life Insurance Co Ltd(SHSE:601336) is 2.91% (As of Today), Highest Dividend Payout Ratio of New China Life Insurance Co Ltd(SHSE:601336) was 0.46. The lowest was 0.07. And the median was 0.21. The  Forward Dividend Yield % of New China Life Insurance Co Ltd(SHSE:601336) is 2.91%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers